Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl-Peptidase IV Inhibitors”

165 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 165 results

Not applicableUnknownNCT03636763
What this trial is testing

Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?

Who this might be right for
Bullous Pemphigoid
Assistance Publique Hopitaux De Marseille 183
Post-approval studies (Phase 4)Study completedNCT04654676
What this trial is testing

DPP4 Inhibitor on Glycemic Variability

Who this might be right for
Diabetes Mellitus, Type 2
University Malaysia Sarawak 12
Testing effectiveness (Phase 2)Study completedNCT06703268
What this trial is testing

A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Haisco Pharmaceutical Group Co., Ltd. 64
Not applicableUnknownNCT01545024
What this trial is testing

Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Nagaoka Red Cross Hospital 60
Large-scale testing (Phase 3)Study completedNCT02273050
What this trial is testing

Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 1,136
Large-scale testing (Phase 3)Study completedNCT01805830
What this trial is testing

Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy

Who this might be right for
Type 2 Diabetes
Handok Inc. 189
Early research (Phase 1)Study completedNCT00551590
What this trial is testing

Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Ludwig-Maximilians - University of Munich 24
Post-approval studies (Phase 4)Study completedNCT02089438
What this trial is testing

DPP-4 Inhibition, Incretins and Islet Function

Who this might be right for
Type 2 Diabetes
Lund University 24
Large-scale testing (Phase 3)Ended earlyNCT00865592
What this trial is testing

Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusType 2 Diabetes
Phenomix 450
Post-approval studies (Phase 4)UnknownNCT02802644
What this trial is testing

The Effect of DPP4 Inhibitor on Vasclular Healing

Who this might be right for
Acute Coronary SyndromeDiabetes Mellitus, Type 2
Chung-Ang University 66
Testing effectiveness (Phase 2)Study completedNCT03751657
What this trial is testing

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 247
Not applicableStudy completedNCT03764631
What this trial is testing

Post-authorization Safety Study in Type 2 Diabetic Patients in Saudi Arabia Treated With Empagliflozin to Assess the Incidence of Ketoacidosis, Severe Complications of Urinary Tract Infection, Volume Depletion, and Dehydration

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,502
Post-approval studies (Phase 4)Study completedNCT02941445
What this trial is testing

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

Who this might be right for
Polycystic Ovary SyndromeBody Weight
University Medical Centre Ljubljana 24
Large-scale testing (Phase 3)Study completedNCT02043054
What this trial is testing

Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)

Who this might be right for
Type 2 Diabetes MellitusCardiovascular Disease
University of Leicester 90
Large-scale testing (Phase 3)Study completedNCT02946541
What this trial is testing

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Who this might be right for
Type 2 Diabetes Mellitus
Dong-A ST Co., Ltd. 160
Post-approval studies (Phase 4)Study completedNCT03267576
What this trial is testing

An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 64
Post-approval studies (Phase 4)WithdrawnNCT02263677
What this trial is testing

Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI

Who this might be right for
Type 2 DiabetesNon-alcoholic Fatty Liver Disease
University of Missouri-Columbia
Large-scale testing (Phase 3)Study completedNCT01137812
What this trial is testing

The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 756
Post-approval studies (Phase 4)Study completedNCT02330406
What this trial is testing

Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial

Who this might be right for
Dipeptidyl-Peptidase 4 InhibitorsLDL CholesterolGlycosylated Hemoglobin+2 more
Institute for Clinical Effectiveness, Japan 353
Large-scale testing (Phase 3)Study completedNCT01106677
What this trial is testing

The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 1,284
Load More Results